Earli
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $60M
Investors
- 7
About Earli
Based in California, US, and founded in 2018 by Chief Executive Officer Cyriac Roeding, co-founder Sam Gambhir and Chief Scientist Officer David Suhy, Earli, Inc. operates as a developer of cancer treatment devices used to detect biomarkers in blood, urine, or breath for early treatment of cancer. In October 2024, Earli, Inc. Earli, Inc. developed a platform known as the synthetic biopsy platform, which is a transformative approach to cancer diagnostics. The company’s technology prompts cancer cells to produce synthetic biomarkers, which can be detected via imaging technologies such as PET scans. In addition, the firm’s platform aids in early cancer detection but also has therapeutic applications by activating the immune system to target and destroy cancer cells. It offers a synthetic biopsy approach that enhances the sensitivity and specificity of cancer detection for an earlier diagnosis, allowing pharmaceutical and biotech companies to create personalized treatments.
Who invested in Earli
7 investors across 2 rounds
See all investors in Earli
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Earli
Who invested in Earli?
Earli has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Earli raised?
Earli has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Earli last raise money?
Earli's most recent round on record is a Series A, in Jan 2021.
What does Earli do?
Based in California, US, and founded in 2018 by Chief Executive Officer Cyriac Roeding, co-founder Sam Gambhir and Chief Scientist Officer David Suhy, Earli, Inc.
Where is Earli headquartered?
Earli is headquartered in Redwood City, US.
Which VCs invest in companies like Earli?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Earli's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Earli? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.